RCUS NYSE · Healthcare · FY 2025-12-31

Arcus Biosciences, Inc.

0.07.615.222.830.4ABVfair 5.04buy —EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 28.19 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4

Price
28.190 USD
Market cap
3.53B USD
P / B
5.60
P / E
EPS
-3.290
DPS / yield
(0.0%)
NAV / share
5.036
Graham number
Z'' score
-0.51
Piotroski F
0 / 9
Beneish M
ROIC vs WACC
-60.3% vs 9.6%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.